OBJECTIVES: The goal of this study was to assess the associations between renal artery calcification (RAC) and mortality in a healthy outpatient cohort with no known cardiovascular disease (CVD). BACKGROUND: Studies in individuals with known diabetes and kidney disease have suggested that RAC confers additional mortality risk independent of coronary artery calcification, but this hypothesis has not been explored in healthier populations. METHODS: RAC was assessed by using computed tomography scan in healthy outpatients with no known CVD. Cox proportional hazards models were used to examine the association of RAC with mortality. RESULTS: The mean age of participants was 57 years; 42.6% were women. RAC was present in 622 (14%) of 4,450 participants. Over a median follow-up of 8.2 years, there were 178 deaths. After adjustment for age, sex, diabetes, smoking, cholesterol, and family history of CVD, the presence of RAC conferred a >60% increased hazard for all-cause mortality (hazard ratio [HR]: 1.63 [95% confidence interval (CI): 1.17 to 2.29]). Adjustment for calcification in other vascular beds attenuated this association (HR: 1.40 [95% CI: 0.99 to 1.97]). Adjustment for hypertension, a potential mediator of the association, did not substantially change the results (HR: 1.44 [95% CI: 1.02 to 2.03]). Adding RAC to a model including Framingham risk and coronary artery calcification improved the predictive ability of the model, from 0.73 to 0.77 (p = 0.0002); the net reclassification index was 14.4% for the addition of RAC. Results for cardiovascular mortality were not significant and were limited by the small number of cardiovascular deaths. CONCLUSIONS: RAC was associated with an increased risk of subsequent all-cause mortality in healthy outpatient individuals, independent of traditional cardiac risk factors. The risk was modestly attenuated by adjustment for vascular calcification in other vascular beds, suggesting partial confounding by systemic calcified atherosclerosis. The effect did not seem to be mediated by hypertension.
OBJECTIVES: The goal of this study was to assess the associations between renal artery calcification (RAC) and mortality in a healthy outpatient cohort with no known cardiovascular disease (CVD). BACKGROUND: Studies in individuals with known diabetes and kidney disease have suggested that RAC confers additional mortality risk independent of coronary artery calcification, but this hypothesis has not been explored in healthier populations. METHODS: RAC was assessed by using computed tomography scan in healthy outpatients with no known CVD. Cox proportional hazards models were used to examine the association of RAC with mortality. RESULTS: The mean age of participants was 57 years; 42.6% were women. RAC was present in 622 (14%) of 4,450 participants. Over a median follow-up of 8.2 years, there were 178 deaths. After adjustment for age, sex, diabetes, smoking, cholesterol, and family history of CVD, the presence of RAC conferred a >60% increased hazard for all-cause mortality (hazard ratio [HR]: 1.63 [95% confidence interval (CI): 1.17 to 2.29]). Adjustment for calcification in other vascular beds attenuated this association (HR: 1.40 [95% CI: 0.99 to 1.97]). Adjustment for hypertension, a potential mediator of the association, did not substantially change the results (HR: 1.44 [95% CI: 1.02 to 2.03]). Adding RAC to a model including Framingham risk and coronary artery calcification improved the predictive ability of the model, from 0.73 to 0.77 (p = 0.0002); the net reclassification index was 14.4% for the addition of RAC. Results for cardiovascular mortality were not significant and were limited by the small number of cardiovascular deaths. CONCLUSIONS: RAC was associated with an increased risk of subsequent all-cause mortality in healthy outpatient individuals, independent of traditional cardiac risk factors. The risk was modestly attenuated by adjustment for vascular calcification in other vascular beds, suggesting partial confounding by systemic calcified atherosclerosis. The effect did not seem to be mediated by hypertension.
Authors: P Gayard; J M Garcier; J Y Boire; A Ravel; N Perez; C Privat; P Lucien; J F Viallet; L Boyer Journal: Cardiovasc Intervent Radiol Date: 2000 Jan-Feb Impact factor: 2.740
Authors: Nathan D Wong; Heidi Gransar; Leslee Shaw; Donna Polk; Johanna H Moon; Romalisa Miranda-Peats; Sean W Hayes; Louise E J Thomson; Alan Rozanski; John D Friedman; Daniel S Berman Journal: JACC Cardiovasc Imaging Date: 2009-03
Authors: P W Wilson; L I Kauppila; C J O'Donnell; D P Kiel; M Hannan; J M Polak; L A Cupples Journal: Circulation Date: 2001-03-20 Impact factor: 29.690
Authors: Matthew J Budoff; Khurram Nasir; Ronit Katz; Junichiro Takasu; J Jeffery Carr; Nathan D Wong; Matthew Allison; Joao A C Lima; Robert Detrano; Roger S Blumenthal; Richard Kronmal Journal: Atherosclerosis Date: 2010-11-26 Impact factor: 5.162
Authors: Matthew A Allison; Dominic DiTomasso; Michael H Criqui; Robert D Langer; C Michael Wright Journal: Vasc Med Date: 2006-11 Impact factor: 3.239
Authors: Matthew A Allison; Elizabeth O Lillie; Dominic DiTomasso; C Michael Wright; Michael H Criqui Journal: J Am Coll Cardiol Date: 2007-10-01 Impact factor: 24.094
Authors: Steven D Shapiro; James Goldman; Susan Morgello; Lawrence Honig; Mitchell S V Elkind; Randolph S Marshall; Jay P Mohr; Jose Gutierrez Journal: Cardiovasc Pathol Date: 2018-10-12 Impact factor: 2.185
Authors: Devesh Vashishtha; Robyn L McClelland; Joachim H Ix; Dena E Rifkin; Nancy Jenny; Matthew Allison Journal: Am J Cardiol Date: 2017-07-24 Impact factor: 2.778
Authors: Daniel A Roseman; Shih-Jen Hwang; Emily S Manders; Christopher J O'Donnell; Ashish Upadhyay; Udo Hoffmann; Caroline S Fox Journal: Am J Cardiol Date: 2013-10-04 Impact factor: 2.778
Authors: Isac C Thomas; Amanda R Ratigan; Dena E Rifkin; Joachim H Ix; Michael H Criqui; Matthew J Budoff; Matthew A Allison Journal: J Am Soc Hypertens Date: 2015-12-13